Creative Biolabs has successfully constructed a series of improved and innovative aptamer platforms to provide fast and better 3D structure determination services for our worldwide customers. Our high-quality services can help you get satisfactory results without repeated redundant trials and obtain a milestone development in your aptamer development.
Contact our team to get an inquiry now!Aptamers are single-stranded oligonucleotides that function as "chemical antibodies" by folding into unique three-dimensional shapes. While primary sequences are easily obtained via SELEX, it is the tertiary structure, comprising hairpins, G-quadruplexes, and pseudoknots, that dictates target recognition. Modern research emphasizes that structural determination is no longer optional; it is the cornerstone of rational design. By resolving these structures at atomic resolution, we enable the visualization of hydrophobic interactions, base stacking, and induced-fit mechanisms that define binding affinity and specificity.
Fig.1 The general SELEX strategy.1
Creative Biolabs offers a comprehensive suite of experimental and computational services to define the 3D topology of aptamers and their target complexes. Our platform bridges the gap between theoretical modeling and empirical validation, ensuring a holistic understanding of molecular function.
Our Core Service Capabilities:
We utilize heteronuclear multidimensional NMR to study aptamers in their native solution state. This is ideal for sequences under 50 nt, providing data on conformational dynamics and ligand-induced folding changes.
For atomic-level blueprints, we provide full crystallization screening of aptamer-target complexes. We resolve diffraction patterns to provide the exact spatial coordinates of every atom within the binding pocket.
We leverage state-of-the-art Cryo-Electron Microscopy to characterize large aptamer-protein assemblies. This "native-state" imaging avoids the artifacts of crystallization and is perfect for membrane-bound targets.
We offer SAXS to determine the low-resolution global shape and flexibility of aptamers in bulk solution, ensuring the 3D models align with physiological behavior.
Initial Technical Consultation: We discuss your aptamer sequence, target properties, and resolution requirements.
Sample Provision: Clients provide purified aptamer sequences (lyophilized or in buffer) and, if applicable, the target protein/molecule.
Standardized Stabilization: We perform thermal conditioning (95℃ for 5 minutes followed by controlled cooling) to ensure homogeneous folding.
Data Acquisition: Samples undergo NMR, X-ray, or Cryo-EM analysis based on the selected strategy.
Structure Refinement: Our bioinformaticians process raw data into a refined 3D PDB model.
Final Delivery: You receive a comprehensive scientific report, the 3D atomic model (PDB format), and high-resolution density maps or spectra.
Fig.2 The cryo-EM structure of the TPP riboswitch.2
In this study, researchers demonstrated a novel strategy for high-resolution of small RNAs by fusing them to a group II intron scaffold. This approach was utilized to resolve the structure of the 86-nucleotide thiamine pyrophosphate (TPP) riboswitch aptamer domain, a historically difficult target due to its small molecular weight. The project results achieved a remarkable 2.5 Å resolution of the TPP riboswitch, providing unprecedented visualization of the ligand-binding pocket. Furthermore, by determining the structure of the ligand-free "apo" state, the researchers observed that the aptamer adopts an open Y-shaped conformation in the absence of its ligand. This case study confirms that scaffolding technologies can bypass the resolution limits of traditional cryo-EM for small aptamers, enabling the capture of multiple conformational states and facilitating more precise ligand-affinity engineering.
A: We use a standardized thermal denaturation and slow-refolding protocol, followed by Dynamic Light Scattering (DLS) and analytical SEC to verify the monodispersity and structural homogeneity of the final sample before data collection.
A: Yes, we utilize high-resolution NMR and X-ray crystallography to resolve aptamer-small molecule complexes, which is vital for biosensor development and metabolite tracking in complex physiological matrices where high sensitivity is paramount.
A: Large aptamers are challenging for NMR; however, we utilize Cryo-EM or "divide and conquer" NMR strategies where we resolve fragments independently and reconstruct the whole model using advanced computational merging and refinement.
A: Yes, we provide integrated molecular docking and MD simulations to complement experimental data, helping to visualize the energetic stability and binding kinetics of the resulting complex under varied physiological conditions.
A: Yes, by identifying flexible regions prone to nuclease attack in the 3D model, we can suggest specific chemical modifications or structural reinforcements to stabilize those areas while maintaining optimal target binding affinity.
A: We employ ensemble modeling and molecular dynamics to capture flexibility. Our cryo-EM workflows also utilize 3D classification to resolve heterogeneous populations, ensuring your final model reflects the most biologically relevant state under varying temperature and buffer conditions.
Creative Biolabs stands as a leader in high-resolution aptamer analysis, combining decades of biological expertise with cutting-edge structural platforms. If you are looking to unlock the full potential of your sequences, we invite you to contact our specialists for a detailed project assessment.
| Cat# | Product Type | Product Name | Specie Reactivity | Applications | Inquiry |
|---|---|---|---|---|---|
| CTS-006 | Serum | Human Complement Serum (Pooled) | Human | Complement fixation assays; Haemolysis Assays | INQUIRY |
| CTS-001 | Serum | Guinea Pig Complement Serum | Guinea pig | Complement fixation assays; Haemolysis Assays | INQUIRY |
| CTR-001 | Antibody | Hemolysin (Rabbit Anti-Sheep Cell Hemolysin) | Sheep | Complement fixation assays; Haemolysis Assays | INQUIRY |
| CTP-461 | Protein | Native Human Complement C1q Protein | Human | ELISA; Functional Assays | INQUIRY |
| CTP-463 | Protein | Native Mouse Complement C1q Protein | Mouse | ELISA; Functional Assays | INQUIRY |
| CTMM-0322-JL15 | Antibody | Mouse Anti-Human C1q Monoclonal Antibody (TJL-03) [HRP] | Human | WB; IHC; ELISA | INQUIRY |
| CTP-051 | Protein | Native Human Complement C3b Protein | Human | ELISA; Functional Assays | INQUIRY |
| CTP-456 | Protein | Native Cynomolgus Monkey Complement C3b Protein | Cynomolgus Monkey | ELISA; Functional Assays | INQUIRY |
| CTApt-113 | Aptamer | Anti-Thrombin Aptamer | Anticoagulant Studies; Structural Complexes; Coagulation Monitoring | INQUIRY | |
| CTApt-217 | Aptamer | Anti-Interleukin 6 (IL-6) Aptamer | ELISA-Like Detection; Inflammatory Disease Screening | INQUIRY | |
| CTApt-615 | Aptamer | Anti-EGFR Aptamer | Targeted Delivery; Cell Internalization; Molecular Imaging | INQUIRY |
References